LCAR-F33S

· Nanjing Legend Biotech Co.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LCAR-F33S, covering 2025-12-29 to 2025-12-29. Get the full timeline:

Most recent: Clinical Trial Update: LCAR-F33S in Treatment of Relapsed/Refractory Multiple Myeloma [NA]